Previous Close | 20.49 |
Open | 20.64 |
Bid | 21.65 x 200 |
Ask | 21.72 x 700 |
Day's Range | 20.23 - 21.68 |
52 Week Range | 5.46 - 21.69 |
Volume | |
Avg. Volume | 526,573 |
Market Cap | 628.477M |
Beta (5Y Monthly) | 2.31 |
PE Ratio (TTM) | 197.09 |
EPS (TTM) | 0.11 |
Earnings Date | Nov 07, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 30.33 |
The United States market has been flat over the last week but is up 38% over the past year, with earnings forecast to grow by 15% annually. In this dynamic environment, identifying stocks that offer strong growth potential and are yet to be widely recognized can provide unique opportunities for investors seeking to capitalize on emerging trends.
INOD's expanding clientele and product offering bodes well for investors. However, high expenses and stretched valuation are concerns.
Grupo Supervielle, Emergent BioSolutions and Innodata are part of the Zacks Screen of the Week article.